Reina-Torres Ester, Wen Joanne C, Liu Katy C, Li Guorong, Sherwood Joseph M, Chang Jason Y H, Challa Pratap, Flügel-Koch Cassandra M, Stamer W Daniel, Allingham R Rand, Overby Darryl R
Department of Bioengineering, Imperial College London, London, United Kingdom.
Department of Ophthalmology, Duke University, Durham, North Carolina, United States.
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1899-1908. doi: 10.1167/iovs.16-20779.
Vascular endothelial growth factor (VEGF) regulates microvascular endothelial permeability, and the permeability of Schlemm's canal (SC) endothelium influences conventional aqueous humor outflow. We hypothesize that VEGF signaling regulates outflow facility.
We measured outflow facility (C) in enucleated mouse eyes perfused with VEGF-A164a, VEGF-A165b, VEGF-D, or inhibitors to VEGF receptor 2 (VEGFR-2). We monitored VEGF-A secretion from human trabecular meshwork (TM) cells by ELISA after 24 hours of static culture or cyclic stretch. We used immunofluorescence microscopy to localize VEGF-A protein within the TM of mice.
VEGF-A164a increased C in enucleated mouse eyes. Cyclic stretch increased VEGF-A secretion by human TM cells, which corresponded to VEGF-A localization in the TM of mice. Blockade of VEGFR-2 decreased C, using either of the inhibitors SU5416 or Ki8751 or the inactive splice variant VEGF-A165b. VEGF-D increased C, which could be blocked by Ki8751.
VEGF is a paracrine regulator of conventional outflow facility that is secreted by TM cells in response to mechanical stress. VEGF affects facility via VEGFR-2 likely at the level of SC endothelium. Disruption of VEGF signaling in the TM may explain why anti-VEGF therapy is associated with decreased outflow facility and sustained ocular hypertension.
血管内皮生长因子(VEGF)调节微血管内皮通透性,而小梁网(SC)内皮的通透性影响传统房水流出。我们假设VEGF信号传导调节流出易度。
我们测量了用VEGF-A164a、VEGF-A165b、VEGF-D或VEGF受体2(VEGFR-2)抑制剂灌注的摘除小鼠眼中的流出易度(C)。在静态培养或循环拉伸24小时后,我们通过ELISA监测人小梁网(TM)细胞中VEGF-A的分泌。我们使用免疫荧光显微镜在小鼠小梁网中定位VEGF-A蛋白。
VEGF-A164a增加了摘除小鼠眼中的C。循环拉伸增加了人TM细胞中VEGF-A的分泌,这与VEGF-A在小鼠小梁网中的定位相对应。使用抑制剂SU5416或Ki8751或无活性剪接变体VEGF-A165b阻断VEGFR-2可降低C。VEGF-D增加了C,这可被Ki8751阻断。
VEGF是传统流出易度的旁分泌调节因子,由TM细胞响应机械应力分泌。VEGF可能在SC内皮水平通过VEGFR-2影响流出易度。小梁网中VEGF信号传导的破坏可能解释了为什么抗VEGF治疗与流出易度降低和持续性高眼压相关。